ZimVie Non Currrent Assets Other Over Time
| ZIMV Stock | USD 14.76 0.23 1.58% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ZimVie Performance and ZimVie Correlation. ZimVie |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZimVie. If investors know ZimVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ZimVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.77) | Revenue Per Share 16.606 | Quarterly Revenue Growth (0.02) | Return On Assets (0.01) | Return On Equity (0.09) |
The market value of ZimVie Inc is measured differently than its book value, which is the value of ZimVie that is recorded on the company's balance sheet. Investors also form their own opinion of ZimVie's value that differs from its market value or its book value, called intrinsic value, which is ZimVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ZimVie's market value can be influenced by many factors that don't directly affect ZimVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ZimVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if ZimVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ZimVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Currrent Assets Other Analysis
Compare ZimVie Inc and related stocks such as Stryker, Boston Scientific Corp, and STERIS plc Non Currrent Assets Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK | 700 K | 157 M | 835 M | 494 M | 738 M | 1.2 B | 830 M | 1.3 B | 2.5 B | 1.4 B | 2 B | 2.2 B | 2.4 B | 2.7 B | 2.8 B |
| BSX | 4.9 M | 281 M | 306 M | 372 M | 425 M | 505 M | 666 M | 688 M | 932 M | 735 M | 545 M | 563 M | 707 M | 680 M | 714 M |
| STE | 100 K | 29.6 M | 10.8 M | 10.3 M | 25.3 M | 29.6 M | 34.6 M | 39.4 M | 60.2 M | 51.6 M | 52.7 M | 70.7 M | 78.1 M | 66.2 M | 69.5 M |
| SNN | (134.6 M) | 17 M | 173 M | 328 M | 84 M | (105 M) | (97 M) | (127 M) | (126 M) | (150 M) | (202 M) | (201 M) | (177 M) | 87 M | 91.3 M |
| CNMD | 100 K | 6.9 M | 150.5 M | 10.3 M | 9.5 M | 11.2 M | 59.2 M | 63.3 M | 62.7 M | 102.3 M | 96.8 M | 98.8 M | 93.9 M | 96.1 M | 100.9 M |
| KIDS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.9 M | (54.1 M) | 8.2 M | 9.5 M | (6 M) | 2.9 M | 3.1 M |
| LUNG | 350 K | 350 K | 350 K | 350 K | 350 K | 350 K | 350 K | 350 K | 350 K | 2.1 M | 536 K | 252 K | 5.4 M | 3.2 M | 2.2 M |
| SIBN | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (2.7 M) | (3.6 M) | 457 K | 269 K | 325 K | 315 K | 374 K | 400 K | 375 K | 325 K | 341.2 K |
| NPCE | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 507 K | 21 K | 368 K | 524 K | 317.9 K |
| CVRX | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 26 K | 27 K | 31.1 K | 29 K |
| OFIX | 1.7 M | 12.3 M | (389.2 M) | 7.4 M | (297.1 M) | 19.2 M | 20.1 M | 21.1 M | 21.4 M | 11.9 M | 17.3 M | 16.7 M | 25.7 M | 33.4 M | 35.1 M |
| AORT | 100 K | 2.6 M | 10.1 M | 4 M | 9.8 M | 5.6 M | 5.5 M | 7.5 M | 7.9 M | 14.2 M | 14.6 M | 8.3 M | 7.3 M | 8.9 M | 5.7 M |
| SGHT | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | 62 K | 168 K | 386 K | 202 K | 211 K | 682 K | 716.1 K |
| INGN | 52 K | 52 K | 79 K | 1.8 M | 97 K | 97 K | 410 K | 765 K | 2.8 M | 4.9 M | 2.7 M | 3.4 M | 2.4 M | 3.8 M | 2 M |
| SRDX | 16.5 M | 2.8 M | 3.2 M | 2 M | 1.5 M | 149 K | 418 K | 967 K | 1.6 M | 4.3 M | 3.7 M | 4.8 M | 3.9 M | 1.1 M | 1 M |
| APYX | 98.7 K | 783 K | 1 M | 674 K | 415 K | 430 K | 212 K | (28 K) | 114 K | 391 K | 807 K | 1.1 M | 1.2 M | 1.7 M | 1.8 M |
ZimVie Inc and related stocks such as Stryker, Boston Scientific Corp, and STERIS plc Non Currrent Assets Other description
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.My Equities
My Current Equities and Potential Positions
| ZimVie Inc | ZIMV |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Colorado; U.S.A |
| Exchange | NASDAQ Exchange |
USD 14.76
Additional Tools for ZimVie Stock Analysis
When running ZimVie's price analysis, check to measure ZimVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZimVie is operating at the current time. Most of ZimVie's value examination focuses on studying past and present price action to predict the probability of ZimVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZimVie's price. Additionally, you may evaluate how the addition of ZimVie to your portfolios can decrease your overall portfolio volatility.